Page last updated: 2024-09-03

caprylates and 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid

caprylates has been researched along with 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid in 1 studies

Compound Research Comparison

Studies
(caprylates)
Trials
(caprylates)
Recent Studies (post-2010)
(caprylates)
Studies
(2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid)
Trials
(2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid)
Recent Studies (post-2010) (2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid)
5,0611002,339704

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achilefu, S; Andrews, R; Craft, JM; De Silva, RA; Lears, KA; Liang, K; Rogers, BE1

Other Studies

1 other study(ies) available for caprylates and 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid

ArticleYear
In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:5

    Topics: Animals; Binding, Competitive; Biological Transport; Bombesin; Caprylates; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Isothiocyanates; Isotope Labeling; Male; Mice; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, Bombesin; Tomography, X-Ray Computed

2012